pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
TYRA-200
Bile Duct Cancer (Cholangiocarcinoma)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
Phase 1
TYRA-430
Metastatic Hepatocellular Carcinoma (HCC)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
Preclinical
TZT-102
Multiple Myeloma (Kahler Disease)
Tezcat Biosciences Inc
0
catalysts
Phase 2
← prev
page 37 of 62
next →
131
Pain
89
Neurology
1
Temferon
Glioblastoma Multiforme (GBM)
Genenta Science SpA
0
catalysts
Phase 3
Tevimbra
Tevimbra (tislelizumab-jsgr)
Small-Cell Lung Cancer
Programmed cell death protein 1
$ONC
BeOne Medicines Ltd.
0
catalysts
Preclinical
Therapeutic Inducers of NK cell Killing (ThINKK)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Centre Hospitalier Universitaire Sainte-Justine
0
catalysts
Marketed
Trisenox
Trisenox (arsenic trioxide)
Acute Promyelocytic Leukemia
Teva Pharmaceuticals USA Inc
0
catalysts
Preclinical
TumoG
Glioblastoma Multiforme (GBM)
IntraGel Therapeutics Ltd
0
catalysts
Preclinical
TumoL
Lung Cancer
IntraGel Therapeutics Ltd
0
catalysts
Phase 3
Tumor lysate, particle only (TLPO) vaccine
Melanoma
Elios Therapeutics LLC
0
catalysts
Phase 2
UB-941
Colon Cancer
UBI Pharma Inc
0
catalysts
Phase 1
UBVV-111
Chronic Lymphocytic Leukemia (CLL)
Umoja BioPharma Inc
0
catalysts
Phase 1
UBX-303
Diffuse Large B-Cell Lymphoma
Ubix Therapeutics Inc
0
catalysts
Preclinical
Undisclosed
Solid Tumor
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
Up-284
Glioblastoma Multiforme (GBM)
Up Therapeutics LLC
0
catalysts
Preclinical
VAC-23
VAC23
Melanoma
Trekka Therapeutics LLC
0
catalysts
Phase 1
VAC-85135
Essential Thrombocythemia
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 1
VAX-014
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Vaxiion Therapeutics Inc
0
catalysts
Phase 2
VBC-103
Metastatic Transitional (Urothelial) Tract Cancer
Avenzo Therapeutics Inc
0
catalysts
Phase 2
VBI-1901
Recurrent Glioblastoma Multiforme (GBM)
VBI Vaccines Inc
0
catalysts
Phase 1
VCC-001
Renal Cell Carcinoma
Vaccentis AG
0
catalysts
Preclinical
VERI-101
Solid Tumor
VerImmune Inc
0
catalysts
Phase 2
VG-161
Bile Duct Cancer (Cholangiocarcinoma)
Virogin Biotech Ltd
0
catalysts
Phase 1
VG-201
Colorectal Cancer
Virogin Biotech Ltd
0
catalysts
Phase 1
VG-203
Solid Tumor
Virogin Biotech Ltd
0
catalysts
Phase 1
VIPER-101
Anaplastic Large Cell Lymphoma (ALCL)
ViTToria Biotherapeutics Inc
0
catalysts
Phase 1
VIR-5500
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$VIR
Vir Biotechnology, Inc.
0
catalysts
Phase 1
VIR-5525
Adenocarcinoma
$VIR
Vir Biotechnology, Inc.
0
catalysts
Preclinical
VIS-DerMap
Basal Cell Carcinoma (Basal Cell Epithelioma)
ArrayPatch Ltd
0
catalysts
Phase 2
VLS-1488
Ovarian Cancer
Volastra Therapeutics Inc
0
catalysts
